Steven K. Burke - 31 Aug 2022 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, Chief Medical Officer
Signature
/s/ Carolyn Rucci, attorney-in-fact for Steven K. Burke
Issuer symbol
AKBA
Transactions as of
31 Aug 2022
Net transactions value
-$416
Form type
4
Filing time
01 Sep 2022, 16:15:30 UTC
Previous filing
16 May 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $416 -1,147 -0.27% $0.3625 418,016 31 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019.
F2 Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2022, under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.